Composite Lysostaphin

Core Identity: A specialized bio-enzymatic antimicrobial agent that specifically targets Staphylococcus aureus (including drug-resistant strains like MRSA). It is a precision weapon embodying the "using bacteria to fight bacteria" strategy.

Core Components & Mechanism:
It is not a single enzyme but a composite system, primarily consisting of:

• Lysostaphin: The primary attacking enzyme. It specifically hydrolyzes the peptidoglycan structure (Gly-Gly bonds) in the cell wall of S. aureus, causing rapid bacterial lysis and death.

• Lysozyme: A supporting enzyme. It hydrolyzes other sites on the bacterial cell wall, creating a synergistic effect with Lysostaphin.

• Other Synergistic Components: Such as humectants, which protect enzymatic activity and enhance penetration.

Key Features:

1. Precision & High Efficacy: Specifically targets and eliminates Staphylococcus aureus without significantly disrupting the skin's normal microbiota.

2. No Drug Resistance: Its physical cell wall disruption mechanism makes it difficult for bacteria to develop resistance.

3. Biosafety: Composed of protein enzymes, it is non-toxic, non-irritating, biodegradable, and environmentally friendly.

Primary Applications:

• Medical Field: Used for preventing and treating infections caused by S. aureus, such as wound infections, rhinitis, acne, and pressure ulcers (bedsores).

Summary:
It is an efficient, precise, and safe new biological antimicrobial agent. It is particularly suitable for addressing various issues caused by Staphylococcus aureus, effectively circumventing the challenge of resistance associated with traditional antibiotics.